Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

83.2K
Overview
83.2K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.8K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.8K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

781
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
781
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.8K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.5K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.5K
Tissue Transplantation01:24

Tissue Transplantation

832
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
832

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: The invisible architects: microbial communities and their transformative role in soil health and global climate changes.

Environmental microbiome·2026
Same author

Improved conditioning for hematopoietic chimerism induces islet tolerance to cure diabetes.

JCI insight·2026
Same author

Superior Chronic Graft-versus-Host Disease-Free Survival with Post-Transplant Cyclophosphamide Relative to Tacrolimus/Methotrexate in Myeloablative HLA-Matched Allogeneic Hematopoietic Cell Transplantation.

Transplantation and cellular therapy·2026
Same author

Posttransplant B cell Development and Function in Patients with B cell Positive SCID Caused by Pathogenic Variants in IL2RG and JAK3.

Journal of clinical immunology·2026
Same author

CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias.

Research square·2025
Same author

The Impact of Anti-CD38 Monoclonal Antibody Therapy on Stem-Cell Mobilization Yields in Patients With Newly Diagnosed Multiple Myeloma (NDMM) Referred From Community and Academic Oncology Practices: Single Center, Real World Data 2021-2024.

Transplantation and cellular therapy·2025

Related Experiment Video

Updated: Jan 2, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.2K

Conditioning Perspectives for Primary Immunodeficiency Stem Cell Transplants.

Peter Shaw1, Judith Shizuru2, Manfred Hoenig3

  • 1Children's Hospital at Westmead, Sydney, NSW, Australia.

Frontiers in Pediatrics
|November 30, 2019
PubMed
Summary
This summary is machine-generated.

Hematopoietic stem cell transplantation (HSCT) conditioning aims to improve engraftment while minimizing toxicity. Novel approaches focus on reducing chemotherapy-related risks and preserving fertility for better long-term outcomes.

Keywords:
chemotherapyconditioninghematopoietic stem cell transplant (HSCT)immunoablationimmunotherapy

More Related Videos

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

15.8K
Isolation and Transplantation of Different Aged Murine Thymic Grafts.
05:47

Isolation and Transplantation of Different Aged Murine Thymic Grafts.

Published on: May 13, 2015

14.4K

Related Experiment Videos

Last Updated: Jan 2, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.2K
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

15.8K
Isolation and Transplantation of Different Aged Murine Thymic Grafts.
05:47

Isolation and Transplantation of Different Aged Murine Thymic Grafts.

Published on: May 13, 2015

14.4K

Area of Science:

  • Pediatric Hematology
  • Immunology
  • Transplantation Medicine

Background:

  • Hematopoietic stem cell transplantation (HSCT) is crucial for treating various pediatric diseases.
  • Conditioning therapy is essential for graft engraftment and preventing rejection, but carries significant risks.
  • Traditional conditioning regimens can lead to severe toxicity, mortality, and long-term complications like infertility.

Purpose of the Study:

  • To review current conditioning strategies in pediatric HSCT.
  • To evaluate the benefits and drawbacks of traditional versus novel conditioning approaches.
  • To explore future directions in non-toxic conditioning for HSCT and gene therapy.

Main Methods:

  • Review of existing literature on HSCT conditioning protocols.
  • Comparison of toxicity profiles and efficacy of different chemotherapy combinations.
  • Discussion of emerging antibody-based conditioning strategies.

Main Results:

  • Traditional busulfan and cyclophosphamide regimens achieve high engraftment but increase mortality and infertility risks.
  • Less intensive regimens (e.g., treosulfan/melphalan with fludarabine) reduce toxicity but may compromise engraftment.
  • Novel approaches show promise for preserving fertility, a critical long-term benefit.

Conclusions:

  • Optimizing HSCT conditioning is vital for improving patient outcomes and reducing long-term adverse effects.
  • Future research focuses on developing non-toxic conditioning methods, potentially using antibodies.
  • Lessons learned from HSCT conditioning refinement are applicable to gene therapy protocols.